Ellevest, Inc. Organon & Co. Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$21.42 - $32.08 $20,370 - $30,508	951 Added 91.18%	1,994 $46,000
Q4 2022 Feb 03, 2023	SELL	$23.31 - $28.61 $2,377 - $2,918	-102 Reduced 8.91%	1,043 $29,000
Q3 2022 Nov 02, 2022	BUY	$23.4 - $34.25 $20,287 - $29,694	867 Added 311.87%	1,145 $27,000
Q2 2022 Jul 18, 2022	SELL	$31.66 - $38.9 $10,542 - $12,953	-333 Reduced 54.5%	278 $9,000
Q1 2022 Apr 19, 2022	BUY	$30.45 - $39.36 $1,339 - $1,731	44 Added 7.76%	611 $21,000
Q4 2021 Jan 24, 2022	SELL	$28.67 - $37.13 $1,290 - $1,670	-45 Reduced 7.35%	567 $17,000
Q3 2021 Oct 19, 2021	BUY	$28.63 - $35.64 $17,521 - $21,811	612 New	612 $20,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.